behavior/neurological
• motor dysfunction in mice injected with tamoxifen at 2 months of age
|
cellular
• nucleolar integrity is disrupted in dopaminergic neurons of tamoxifen treated mice
|
• about 40% decrease in COX activity is seen 2 weeks after tamoxifen treatment, indicating mitochondrial damage is an early consequence of nucleolar damage
|
• induction of nucleolar stress is seen in dopaminergic neurons of tamoxifen treated mice
|
• dopaminergic neurons of tamoxifen-induced mice are more vulnerable to the oxidative damage induced by MPTP than controls showing an approximate 40% loss of neurons compared to 15% in controls
|
• dopaminergic neurons show higher levels of oxidative stress markers at 4 weeks after tamoxifen treatment
|
homeostasis/metabolism
• mice injected with tamoxifen at 2 months of age exhibit a decline in dopamine content in the striatum
|
nervous system
• mice injected with tamoxifen at 2 months of age show a progressive differential loss of dopaminergic neurons in substantia nigra and ventral tegmental area
• tamoxifen-induced mice treated with pifithrin-alpha, a chemical inhibitor of Trp53 show prevention of dopaminergic neuron loss
|
• mice injected with tamoxifen at 2 months of age exhibit neurodegeneration of TH+ neurons
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Parkinson's disease | DOID:14330 |
OMIM:PS168600 |
J:168232 , J:242309 |